Anticholinergic Deprescription in Schizophrenia
Phase 4
105
about 4.4 years
40–70
1 site in PA
What this study is about
Researchers are testing whether stopping unnecessary anticholinergic medications can improve quality of life, functioning, and thinking skills in people with schizophrenia. Participants will be randomly assigned to either continue taking their current medication or undergo a deprescribing process if deemed clinically appropriate. The trial will last for 1610 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Anticholinergic Deprescription
- 2.Take No Anticholinergic Deprescription
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Change in scores on quality of life assessments.
Psychiatry / Mental Health